Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Astronics
ATRO
$3.84B
| $716K | ﹤0.01% |
49,326
+38,426
| +353% | +$504K |
|
3577
Xponential Fitness
XPOF
$211M
| $716K | ﹤0.01% |
55,544
-40,206
| -42% | -$545K |
|
3578
Phibro Animal Health
PAHC
$1.39B
| $716K | ﹤0.01% |
61,812
+26,174
| +73% | +$295K |
|
3579
Paysafe
PSFE
$375M
| $715K | ﹤0.01% |
55,884
+38,932
| +230% | +$430K |
|
|
SPWR
3580
DELISTED
SunPower Corporation Common Stock
SPWR
| $711K | ﹤0.01% |
147,108
+94,865
| +182% | +$453K |
|
3581
Nurix Therapeutics
NRIX
$2.65B
| $709K | ﹤0.01% |
68,739
+1,272
| +2% | +$8.72K |
|
|
CBAY
3582
CALL
DELISTED
Cymabay Therapeutics
CBAY
| $709K | ﹤0.01% |
30,000
-53,800
| -64% | -$958K |
|
|
CBAY
3583
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $709K | ﹤0.01% |
+30,000
| New | +$534K |
|
3584
Reynolds Consumer Products
REYN
$5.59B
| $707K | ﹤0.01% |
26,340
-1,246
| -5% | -$32.5K |
|
|
ONTF
3585
DELISTED
ON24
ONTF
| $704K | ﹤0.01% |
89,340
+36,008
| +68% | +$250K |
|
|
SFIX
3586
Stitch Fix
SFIX
$560M
| $703K | ﹤0.01% |
196,857
+116,720
| +146% | +$412K |
|
3587
LivePerson
LPSN
$32.3M
| $702K | ﹤0.01% |
12,351
+6,145
| +99% | +$283K |
|
|
TWKS
3588
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $702K | ﹤0.01% |
145,886
+112,441
| +336% | +$461K |
|
3589
Sinclair Inc
SBGI
$1.03B
| $702K | ﹤0.01% |
53,842
+34,297
| +175% | +$421K |
|
3590
TransAlta
TAC
$3.93B
| $701K | ﹤0.01% |
84,348
+15,333
| +22% | +$124K |
|
3591
Kura Sushi USA
KRUS
$593M
| $700K | ﹤0.01% |
9,214
+7,180
| +353% | +$464K |
|
3592
Baytex Energy
BTE
$2.92B
| $700K | ﹤0.01% |
210,911
+14,714
| +7% | +$57K |
|
3593
Banco Santander Chile
BSAC
$16.6B
| $700K | ﹤0.01% |
35,900
| – | – |
|
|
TPC
3594
Tutor Perini Cor
TPC
$5.21B
| $699K | ﹤0.01% |
76,797
+42,341
| +123% | +$337K |
|
3595
DocGo
DCGO
$62.6M
| $695K | ﹤0.01% |
124,360
-77,223
| -38% | -$443K |
|
3596
MeiraGTx Holdings
MGTX
$1.21B
| $693K | ﹤0.01% |
98,652
+31,317
| +47% | +$155K |
|
3597
AngioDynamics
ANGO
$649M
| $692K | ﹤0.01% |
88,263
+50,108
| +131% | +$348K |
|
|
AGS
3598
DELISTED
PlayAGS
AGS
| $689K | ﹤0.01% |
81,753
+44,541
| +120% | +$330K |
|
3599
AbCellera Biologics
ABCL
$2.12B
| $689K | ﹤0.01% |
120,657
+99,671
| +475% | +$462K |
|
3600
MetroCity Bankshares
MCBS
$1.03B
| $689K | ﹤0.01% |
28,670
+22,207
| +344% | +$474K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.